Sandbox28

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
in the two opposite quadrants and <scene name='Sandbox28/Alpha_helix/1'>alpha helices</scene> in the other two opposite quadrants.
in the two opposite quadrants and <scene name='Sandbox28/Alpha_helix/1'>alpha helices</scene> in the other two opposite quadrants.
There are also two active sites that can be seen here: <scene name='Sandbox28/Ac1/1'>active site 1</scene> <scene name='Sandbox28/Ac2/1'>active site 2</scene>
There are also two active sites that can be seen here: <scene name='Sandbox28/Ac1/1'>active site 1</scene> <scene name='Sandbox28/Ac2/1'>active site 2</scene>
 +
 +
This view shows a
 +
<scene name='Sandbox28/Hydrophobicalpha/1'>hydrophobic element</scene> of an alpha helix (in red) on the surface of the protein.
{{STRUCTURE_1h8f | PDB=1h8f | SCENE= }}
{{STRUCTURE_1h8f | PDB=1h8f | SCENE= }}

Revision as of 07:01, 4 March 2009

GLYCOGEN SYNTHASE KINASE 3 BETA

Glycogen Synthase Kinase 3 Beta has in the two opposite quadrants and in the other two opposite quadrants. There are also two active sites that can be seen here:

This view shows a of an alpha helix (in red) on the surface of the protein.


PDB ID 1h8f

Drag the structure with the mouse to rotate
1h8f, resolution 2.80Å ()
Ligands:
Activity: Non-specific serine/threonine protein kinase, with EC number 2.7.11.1
Resources: FirstGlance, OCA, RCSB, PDBsum
Coordinates: save as pdb, mmCIF, xml



Publication Abstract from PubMed

Glycogen synthase kinase 3 beta (GSK3 beta) plays a key role in insulin and Wnt signaling, phosphorylating downstream targets by default, and becoming inhibited following the extracellular signaling event. The crystal structure of human GSK3 beta shows a catalytically active conformation in the absence of activation-segment phosphorylation, with the sulphonate of a buffer molecule bridging the activation-segment and N-terminal domain in the same way as the phosphate group of the activation-segment phospho-Ser/Thr in other kinases. The location of this oxyanion binding site in the substrate binding cleft indicates direct coupling of P+4 phosphate-primed substrate binding and catalytic activation, explains the ability of GSK3 beta to processively hyperphosphorylate substrates with Ser/Thr pentad-repeats, and suggests a mechanism for autoinhibition in which the phosphorylated N terminus binds as a competitive pseudosubstrate with phospho-Ser 9 occupying the P+4 site.

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition., Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH, Cell. 2001 Jun 15;105(6):721-32. PMID:11440715

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Personal tools